TAG:
genomics
Sunquest, Towers Perrin, Aetna, Quest Diagnostics, Roche Diagnostics, Careside
By Robert Michel | From the Volume VIII No. 16 – November 26, 2001 Issue
SUNQUEST REAFFIRMS LONG-TERM COMMITMENT TO COPATHPLUS PRODUCT EXPECT A FASCINATING competitive battle in the market for anatomic pathology software now that Cerner Corporation is acquiring Dynamic Healthcare Technologies, Inc. (DHT) DHT is the developer an…
“November 5, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. #15 – November 5, 2001 Issue
It’s a milestone in the Pap smear testing marketplace. Cytyc Corporation, in its third quarter financial report, now claims its Thin-Prep® product has 51% of the national market for Pap testing. Estimates are that 55 million Pap tests are done annually in the United States. A 51% …
LabCorp to Help Collect Family DNA Specimens
By Robert Michel | From the Volume VIII No. 13 – September 24, 2001 Issue
CEO SUMMARY: DNA testing will be a primary tool in identifying victims of this major disaster. Officials in New York City are formulating a plan whereby private labs will do DNA testing in conjunction with New York State Police laboratories. Laboratory Corporation of America has been desi…
Big Jump Predicted In Health Insurance Costs
By Robert Michel | From the Volume VIII No. 11 – August 13, 2001 Issue
CEO SUMMARY: Spiraling health costs are about to become a headline issue once again. There is widespread evidence that health insurers are seeking premium increases of 20% from the nation’s biggest employers. Aetna recently announced a second quarter 2001 operating loss of $95.9 million…
“August 13, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 11 – August 13, 2001 Issue
In recent years he’s become an influential “behind the scenes” guy within the lab industry. Now Heywood D. Cochrane, Jr. is joining the Board of Directors at AmeriPath, Inc., based in Riviera Beach, Florida. Most laboratorians know Cochrane from his tour as President and CEO of…
University of Minnesota Pathologists Organize Tissue Archives
By Robert Michel | From the Volume VIII No. 8 – June 11, 2001 Issue
CEO SUMMARY: Pathologists at the University of Minnesota Medical School are working to create an electronic data base that covers the more than 100 years of autopsy cases that have been archived and stored. Their goal is to use this information to improve teaching and to further research …
“June 11, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 8 – June 11, 2001 Issue
Here’s a late-breaking story: Tropical Storm Allison hammered Houston and East Texas over the weekend. More than 30 inches of rain caused wide-spread flooding in the Houston Metropolitan Area. Hospitals in the Medical Center were hard hit. Memorial Hermann Hospital closed on Saturd…
Tissue Banking May Be Source Of New Pathology Revenues
By Robert Michel | From the Volume VIII No. 5 – April 9, 2001 Issue
CEO SUMMARY: Evidence is accumulating that tissue banking may be where the “rubber meets the road;” where pharma money funds technology enhancements that directly benefit the profession of pathology. Without question, the need by pharma, biotech, and genomic companies to access, analy…
Market Changes Lead LabCorp To Follow New Strategic Direction
By Robert Michel | From the Volume VIII No. 4 – March 19, 2001 Issue
CEO SUMMARY: When formed in 1995, Laboratory Corporation of America faced a financially-hostile marketplace for lab testing services. However, strategic planning retreats in 1997 and 1999 were pivotal in redirecting this billion-dollar lab behemoth toward financial stability. During 2000,…
Two Labs Complete IPOs, AML May be Next in Line
By Robert Michel | From the Volume VIII No. 1 – January 15, 2001 Issue
CEO SUMMARY: During the year 2000, investors liked the performance of clinical labs. When stock market woes surfaced this fall, it was not enough to dampen investor interest in Dynacare and Specialty Laboratories. Both companies funded their initial public stock offering in a difficult ma…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized